The effect of PEG molecular weights on dissolution behavior of simvastatin in solid dispersions

Iranian Journal of Pharmaceutical Research

Volumn 12, Issue SUPPL., 2013, Pages 9-18

  Bolourchian, Noushin ^a,b   Mahboobian, Mohammad Mehdi ^a   Dadashzadeh, Simin ^a,b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Dissolution; PEG molecular weight; Simvastatin; Solid dispersion; Solubility

Indexed keywords

DRUG CARRIER; MACROGOL; SIMVASTATIN;

ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG MIXTURE; DRUG SOLUBILITY; HYDROPHILICITY; INFRARED SPECTROSCOPY; MOLECULAR WEIGHT; PARTICLE SIZE; VISCOSITY; WETTABILITY; X RAY DIFFRACTION; X RAY POWDER DIFFRACTION;

EID: 84875134614     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Malloy MJ and Kane JP. Agents used in dyslipidemia. In: Katzung BG, Masters SB and Trevor AJ. (eds.) Basic and clinical pharmacology. 11th ed. McGraw-Hill, Boston (2009) 612-13.
2. Varshosaz J, Tavakoli N and Salamat FA. Enhanced dissolution rate of simvastatin using spherical crystallization technique. Pharm. Dev. Technol. (2010) Aug:1-7.
3. Zhang Z, Bu H, Gao Z, Huang Y, Gao F and Li Y. The characteristics and mechanism of simvastatin loaded lipid nanoparticles to increase oral bioavailability in rats. Int. J. Pharm. (2010) 394:147-53.
4. Rao M, Mandage Y, Thanki K and Bhise S. Dissolution improvement of simvastatin by surface solid dispersion technology. Diss. Tech. (2010): 27-34.
5. Leuner C and Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur. J. Pharm. Biopharm. (2000) 50: 47-60.
6. Krishnamoorthy V, Nagalingam A, Ranjan Prasad VP, Parameshwaran S, George N and Kaliyan P. Characterization of Olanzapine-Solid Dispersions. Iranian J. Pharm. Res. (2011) 10:13-23.
7. Okonogi S and Puttipipatkhachorn S. Dissolution improvement of high drug-loaded solid dispersion. AAPS Pharm. Sci. Tech. (2006) 7: E148-E153.
8. Mura P, Moyano JR, Gonzalez-Rodriguez ML, Rabasco-Alvarez AM, Cirri M and Maestrelli F. Characterization and dissolution properties of ketoprofen in binary and ternary solid dispersions with polyethylene glycol and surfactants. Drug Dev. Ind. Pharm. (2005) 31: 425-34.
9. Al-Hamidi H, Edwards AA, Mohammad MA and Nokhodchi A. To enhance dissolution rate of poorly water-soluble drugs: glucosamine hydrochloride as a potential carrier in solid dispersion formulations. Colloids Surf. B Biointerfaces. (2010) 76: 170-8.
10. Han HK, Lee BJ and Lee HK. Enhanced dissolution and bioavailability of biochanin A via the preparation of solid dispersion: In-vitro and in-vivo evaluation. Int. J. Pharm. (2011) 415: 89-94.
11. Li S, Liu Y, Liu T, Zhao L, Zhao J and Feng N. Development and in-vivo assessment of the bioavailability of oridonin solid dispersions by the gas anti-solvent technique. Int. J. Pharm. (2011) 411: 172-7.
12. Damian F, Blaton N, Naesens L, Balzarini J, Kinget R, Augustijns P and Van den Mooter G. Physicochemical characterization of solid dispersions of the antiviral agent UC-781 with polyethylene glycol 6000 and Gelucire 44/14. Eur. J. Pharm. Sci. (2000) 10: 311-22.
13. Chiou WL and Riegelman S. Pharmaceutical applications of solid dispersion systems. J. Pharm. Sci. (1971) 60: 1281-302.
14. Craig DQ. The mechanisms of drug release from solid dispersions in water-soluble polymers. Int. J. Pharm. (2002) 231: 131-44.
15. Keck CM and Müller RH. Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation. Eur. J. Pharm. Biopharm. (2006) 62: 3-16.
16. De Waard H, Hinrichs WLJ, Visser MR, Bologna C and Frijlink HW. Unexpected differences in dissolution behavior of tablets prepared from solid dispersions with a surfactant physically mixed or incorporated. Int. J. Pharm. (2008) 349: 66-73.
17. Hancock BC and Parks M. What is the true solubility advantage for amorphous pharmaceuticals? Iranian J. Pharm. Res. (2000) 17: 397-404.
18. Patel R andPatel M. Preparation, characterization, and dissolution behavior of a solid dispersion of simvastatin with polyethylene glycol 4000 and polyvinylpyrrolidone k30. J. Disper. Sci. Tech. (2008) 29: 193-204.
19. Silva TD, Arantes VT, Resende JA, Speziali NL, de Oliveira RB and Vianna-Soares CD. Preparation and characterization of solid dispersion of simvastatin. Drug Dev. Ind. Pharm. (2010) 36: 1348-55.
20. Bashiri-Shahroodi A, Nassab PR, Szabó-Révész P and Rajkó R. Preparation of a solid dispersion by a dropping method to improve the rate of dissolution of meloxicam. Drug Dev. Ind. Pharm. (2008) 34: 781-8.
21. Newa M, Bhandari KH, Kim JO, Im JS, Kim JA, Yoo BK, Woo JS, Choi HG and Yong CS. Enhancement of solubility, dissolution and bioavailability of ibuprofen in solid dispersion systems. Chem. Pharm. Bull. (2008) 56: 569-74.
22. Pathak D, Dahiya S and Pathak K. Solid dispersion of meloxicam: factorially designed dosage form for geriatric population. Acta Pharm. (2008) 58: 99-110.
23. Laitinen R, Suihko E, Bjorkqvist M, Riikonen J, Lehto VP, Jarvinen K and Ketolainen J. Perphenazine solid dispersions for orally fast-disintegrating tablets: physical stability and formulation. Drug Dev. Ind. Pharm. (2010) 36: 601-13.
24. Bley H, Fussnegger B and Bodmeier R. Characterization and stability of solid dispersions based on PEG/polymer blends. Int. J. Pharm. (2010) 390: 165-73.
25. Dehghan MHG and Jafar M. Improving dissolution of meloxicam using solid dispersions. Iranian J. Pharm. Res. (2006) 5: 231-238.
26. Sahoo NG, Kakran M, Li L, Judeh Z and Müller RH. Dissolution enhancement of a poorly water-soluble antimalarial drug by means of a modified multi-fluid nozzle pilot spray drier. Mater. Sci. Eng. C. (2011) 31: 391-399.
27. Narang AS and Srivastava AK. Evaluation of solid dispersions of clofazimine. Drug Dev. Ind. Pharm. (2002) 28: 1001-13.
28. Janssens S, Denivelle S, Rombaut P and Van den Mooter G. Influence of polyethylene glycol chain length on compatibility and release characteristics of ternary solid dispersions of itraconazole in polyethylene glycol/hydroxypropylmethylcellulose 2910 E5 blends. Eur. J. Pharm. Sci. (2008) 35: 203-10.
29. Ozkan Y, Doganay N, Dikmen N and Işimer A. Enhanced release of solid dispersions of etodolac in polyethylene glycol. Il. Farmaco. (2000) 55: 433-8.
30. Shah JC, Chen JR and Chow D. Preformulation study of etoposide: II. Increased solubility and dissolution rate by solid-solid dispersions. Int. J. Pharm. (1995) 113: 103-11.
31. Khan KA. The concept of dissolution efficiency. J. Pharm. Pharmacol. (1975) 27: 48-9.
32. Valizadeh H, Nokhodchi A, Qarakhani N, Zakeri-Milani P, Azarmi S, Hassanzadeh D and Löbenberg R. Physicochemical characterization of solid dispersions of indomethacin with PEG 6000, Myrj 52, lactose, sorbitol, dextrin, and Eudragit E100. Drug Dev. Ind. Pharm. (2004) 30: 303-17.
33. Ambike AA, Mahadik KR and Paradkar A. Spray-dried amorphous solid dispersions of simvastatin, a low Tg drug: in-vitro and in-vivo evaluations. Pharm. Res. (2005) 22: 990-8.